CN1176699C - Lupus treating medicine - Google Patents
Lupus treating medicine Download PDFInfo
- Publication number
- CN1176699C CN1176699C CNB021245827A CN02124582A CN1176699C CN 1176699 C CN1176699 C CN 1176699C CN B021245827 A CNB021245827 A CN B021245827A CN 02124582 A CN02124582 A CN 02124582A CN 1176699 C CN1176699 C CN 1176699C
- Authority
- CN
- China
- Prior art keywords
- disease
- blood
- kidney
- curing
- tissues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese patent medicine named lupus curing medicine used for curing chronic and stubborn disease of lupus erythematosus, which is prepared according to the characteristics of the disease. The disease is collagen and immunological disease, and the causes of the disease may be the disorder of immune systems, reduced functional or reduced normocellular phagocytosis capability. In the diseases, the activity of lymphokine and lymphocyte is enhanced. The lymphokine and the lymphocyte mainly penetrate to the kidney and blood to form connective tissues with renal cells, glomeruluses, kidney protein, etc., and phagocytose and damage the function of renal tissues. Firstly, the pathological changes of the kidney are formed. Then, the pathological changes spread to skin tissues, blood tissues and organs, such as the heart, liver, lung, etc. Usly stated, the Chinese patent medicine aims to enhance the immunological function and the disease resistant capability of organisms, restrain the generation of the lymphokine and the growth of the lymphocyte in the diseases, defense infection and a great variety of complications in the diseases, reduce the occurrence of common cold, and lighten the symptom of common cold. The Chinese patent medicine has reasonable prescription of restraining bacteria, resisting inflammation, detoxicating, promoting urination, eliminating swelling, nourishing blood, curing blood, invigorating the kidney, curing the kidney, etc., and has strong pathological symptomatic performance of medication.
Description
Affiliated technical field
The present invention relates to treat the Chinese patent drug of chronic disease lupus erythematosus.
Background technology
Medical circle for the main medication of the treatment of chronic disease lupus erythematosus is at present: cortex hormone of aadrenaline and immunodepressant, the hormone drug prednisone is main according to durable medicine for this disease: prednisone has stronger anti-inflammatory, antitoxin, antiallergy, antishock effect, thereby suppresses connective tissue proliferation, reduce histamine and discharge and reduce oozing out of inflammation. This product can also make red blood cell, blood platelet and content of hemoglobin increase, can acidophil, and reduce lymphocyte, and suppress cellular immunity and liquid immunity. The immunodepressant basic simlarity is in hormone: be better than prednisone such as its immune suppression function of Cyclosporin A, for the impact of normal cell phagocytic function possibly less than prednisone. But use for a long time the bad reaction of hormone and inhibitor more also similar: 1. to reduce defensive enginery and the immunologic function of body, increase the weight of easily the state of an illness and accompanying infection; 2. water and salt metabolic disturbance, low potassium and water-sodium retention occur; 3. hypercortisonism disease appears during the medication; 4. after the drug withdrawal adrenal corticalinsufficiency can appear; 5. can bring out or increase the weight of peptic ulcer: 6. can bring out hypertension, artery sclerosis, diabetes: 7. osteoporosis; 8. bring out the mental symptoms such as excitement, excitement: the 9. toxic and side effect of liver kidney; 10. the effect that pathology is not had radical cure.
Summary of the invention
Not enough for the result for the treatment of of chronic disease lupus erythematosus in order to overcome existing medicine, and the problem of radical cure effect, the invention provides a kind of lupus erythematosus medication that obvious result for the treatment of and radical cure effect are arranged.
The present invention treats the technical scheme that lupus erythematosus takes: the phagocytic function that strengthens the strong endothelial system of net, improve resistance against diseases and the immunologic function of body, suppress generation and the lymphocytic growth of this sick lymphokine: reduce the generation of flu and alleviate the symptom of flu, drive anti-the infection and this sick multiple complications; Antibacterial, anti-inflammatory, detoxifcation, inducing diuresis to reduce edema, removing blood stasis for promoting tissue regeneration, liver-kidney tonifying, strengthening the muscles and bones, enrich blood, invigorate blood circulation, hematopoiesis, control blood, control kidney: obviously be better than the effect of existing medicine treatment lupus erythematosus, overcome bad reaction and the side-effect problem of existing medication.
This medicine is now taken after mixing it with water for powder, day therapeutic dose 66 gram minute secondaries. Sooner or later take medicine for 9, can be conducive to bearing and absorbing of stomach, 6 months courses for the treatment of, Long-term taking medicine can recover your health. This medicine needs to be condensed into electuary or pill through modern technologies, is convenient to take.
Points for attention: use for a long time the patient of hormone and immunodepressant, need progressively decrement and with a small amount of maintenance dose, can not all standing.
The effect that the present invention is useful is, can effectively treat the chronic disease lupus erythematosus, has to promote normal immunity, suppresses the disease epidemic disease, and strengthening vital QI to eliminate pathogenic factors has this sick effect of radical cure, has no side effect, and has preferably cure rate.
The composition of medicine, effect show, technical essential.
Prescription medicine name | The powder feed ration | The effect of medicine in we | Technical essential |
The Radix Astragali | 5g | The tonifying middle-Jiao and Qi inducing diuresis to reduce edema | We are with the Radix Astragali, the fruit of Chinese wolfberry, barrenwort, the bark of eucommia, Psoralea corylifolia, dandelion; The multiple pharmacological effect such as qi-restoratives, hematopoiesis, anti-inflammatory: the phagocytic activity that strengthens reticuloendothelial system, improve the immunologic function of body, liquid, cell: with the Radix Astragali, Radix Angelicae Sinensis, Psoralea corylifolia: in the tonifying spleen benefit, by the fruit of Chinese wolfberry, the bark of eucommia, Psoralea corylifolia, barrenwort, radix achyranthis bidentatae, Fructus Corni: kidney-supplementing liver-boosting, strengthening the muscles and bones, again by Radix Angelicae Sinensis, the fruit of Chinese wolfberry, Psoralea corylifolia, radix achyranthis bidentatae: beneficial blood, hematopoiesis, enrich blood, invigorate blood circulation; Many medicines are made a concerted effort with the resistance against diseases that improves body, are driven anti-the infection and complication, close the effect of dispeling the wind of barrenwort, the capsule of weeping forsythia, reduce flu and reduce the symptom of catching a cold, again by dandelion, Sargent gloryvine, the capsule of weeping forsythia, flea stop, field pennycress, betel nut, Phytolacca acinosa processed: anti-inflammatory heat-clearing, removing toxicity for eliminating carbuncles, inducing diuresis to reduce edema, removing blood stasis for promoting tissue regeneration, drive the anti-disease epidemic disease that infects, suppresses, close again safflower, the seed of cowherb, radix achyranthis bidentatae: allow all medicines enter blood and control blood, also by the root of bidentate achyranthes, Phytolacca acinosa: draw all medicines and enter kidney and control kidney. We are whole, and immunosupress, tonification and purgation in combination, the therapeutic action of strengthening vital QI to eliminate pathogenic factors. |
Radix Angelicae Sinensis | 5g | Enriching blood invigorates blood circulation controls blood and unstings | |
The fruit of Chinese wolfberry | 5g | The benefit blood liver-kidney tonifying that nourishes blood | |
Barrenwort | 5g | The sharp bone of the kidney tonifying of dispelling rheumatism | |
Fructus Corni | 4g | The kidney-supplementing liver-boosting convergence is astringent or styptic treatment for spontaneous sweating | |
The bark of eucommia | 4g | The kidney-supplementing liver-boosting strengthening the muscles and bones | |
Psoralea corylifolia | 3g | The solid unit of the strong bone of kidney tonifying temperature spleen | |
Radix achyranthis bidentatae | 4g | The promoting blood circulation inducing diuresis to reduce edema | |
Betel nut | 4g | Promoting the circulation of qi disappears and amasss the laxative detumescence | |
Safflower | 3g | Benefit blood promoting blood circulation to disperse blood clots and relieves pain | |
The seed of cowherb | 4g | The promoting blood circulation inducing diuresis to reduce edema | |
Sargent gloryvine | 4g | The pain promoting blood circulation that disappears detoxifies | |
The capsule of weeping forsythia | 3g | The clearing heat and detoxicating carbuncle dissipating bind that disappears | |
Dandelion | 4g | The heat reliving and toxin-eliminating inducing diuresis to reduce edema | |
Flea stops | 2.5g | The clearing heat and detoxicating carbuncle detumescence that disappears | |
Patrinia scaniosaefolia early | 4g | The removing toxicity for eliminating carbuncles removing blood stasis for promoting tissue regeneration | |
Phytolacca acinosa processed | 2.5g | The detoxicating and resolving a mass inducing diuresis to reduce edema |
Reflect for example effect:
Zhong Xiu, woman, 46 years old live the husky well head of Yancheng City residential quarter
Illness: lupus erythematosus, medical history 10 years. Former therapeutic process: mainly in the Yancheng City First Academy, the treatment of total institute of Nanjing Military Command: for many years main medication is with anti-hormone and inhibitor, and last year is to the Suzhou Chinese traditional treatment, because the adverse consequences that long-term use prednisone etc. cause; Immunologic function and resistance against diseases are almost nil, go out the pulmonary infection that flu causes in last Dec, and the state of an illness is critical. Proof is included in the neither ideal of Chinese traditional treatment in Suzhou thus. Therapeutic process and effect: take this medicine on February 10th, 2002, to June 10 Nikkei took this medicine 4 months, the state of an illness is clearly better, spirit is healthy and vigorous, immunity and resistance against diseases strengthen, checking and chemically examining index has obvious improvement, has significant result for the treatment of.
The chemical analysis of medicine and pharmacological action
1, the Radix Astragali: contain sucrose, glucuronic acid, folic acid, choline, amaroid, mucilaginous substance; Antibiotic, antitoxin, disease-resistant, cardiac stimulant, diuresis, step-down, hemangiectasis, stimulating central nervous system system strengthen the phagocytic activity of endothelial system, improve the immunologic function of cell.
2, Radix Angelicae Sinensis: contain volatile oil, water-soluble alkaloid, sucrose, Cobastab12Deng; Antibiotic, anti-inflammatory, protect the liver, diuresis, excited small intestine, wing light smooth muscle, the strong artery of expansion hat increases CF, reduces MCO, reduces hematoblastic gathering, antithrombotic formation.
3, the fruit of Chinese wolfberry: contain Luo Busu, thiamine, riboflavin, Yan acid, ascorbic acid, linoleic acid, vitamin etc.; Hypoglycemic, cholesterol, blood pressure have cardiotonic, and the fruit of Chinese wolfberry can promote liver cell regeneration, increase serum, and the hematopoiesis function is arranged, and central and not tip parasympathetic nerve effect are arranged, and strengthen the phagocytic activity of the strong endothelial system of net, improve the immunologic function of liquid.
4, barrenwort: contain icariine, ceryl alcohol, phytosterol, hentriacontane, polysaccharide, tannin, oil, brown eleostearic acid, stearic acid, linoleic acid; Anti-inflammatory, antibiotic, reducing blood lipid, blood sugar, blood pressure, increase CF can be expanded peripheral vascular, increase the acra CBF, improve microcirculation, expansion of cerebral vascular, increase cerebral blood flow (CBF), the effect of male sex hormone sample is arranged, the effect of inducement interferon is arranged, promote the immunologic function of body.
5, Fructus Corni: contain cornin, saponin, tannin, gallic acid, malic acid, vitamin A; Antibacterial, diuresis, step-down, the leucocyte that causes because of chemotherapy or radiotherapy descended the function that makes its rising.
6, the bark of eucommia: contain gutta-percha, glucoside, alkaloid, pectin, resin, organic acid, fat, aldose chlorogenic acid, vitamin C; Anti-inflammatory, diuresis, step-down, calmness, analgesia; Hemangiectasis, reduction serum cholesterol, the immunologic function of enhancing body.
7, Psoralea corylifolia: contain volatile oil, Corylifolinin, AP class material (being mainly psoralen and different psoralen); Corylifolinin is coronary artery dilator significantly, can regulate neural and hematological system, promotion marrow hemopoiesis, enhancing immunity and endocrine function.
8, radix achyranthis bidentatae: contain sylvite, triterpenoid saponin (latter is hydrolyzed rear generation oleanolic acid); The effects such as diuresis, step-down spasmolysis, analgesia are arranged.
9, betel nut; Contain alkaloid: be mainly arecaline, arecaidine, guvacoline, condensed tannin, fat, areca red; Contained alkaloid has the paralysis effect to Enterozoa, and betel nut can increase the secretion of the liquid secretion of alimentary canal taste and bile duct, gall bladder bile.
10, safflower: contain safflower yellow, carthamin, safflower quinone glucoside, neocarthamin, safflower polysaccharide etc.; Excited uterus, intestinal tube, blood vessel, kidney vascular smooth muscle; Strengthen it and shrink the minimizing renal blood flow, it is active to increase fibrinoclase, suppresses platelet aggregation, antithrombotic formation, increase coronary artery and myocardial nutritional flow amount, reduce cholesterol, total fat, three nitric acid, glyceric acid, aliphatic acid, blood pressure, improve microcirculation.
11, the seed of cowherb: contain the multiple saponins such as seed of cowherb glucoside. Antibacterial, anti-inflammatory, antiviral; Excited vascular smooth muscle.
12, Sargent gloryvine: contain tannin; Antibacterial, anti-inflammatory, detoxifcation; Suppress hematoblastic gathering, antithrombotic formation, increase CF, improve myocardium oxygen-resistant ability, coronary artery dilator dwindles myocardial infarct size.
13, the capsule of weeping forsythia: contain forsythol, oleanolic acid, saponin, volatile oil, a large amount of citrin; The effects such as tell in antibacterial, anti-inflammatory, detoxifcation, analgesic, antiviral, antiallergy, anti-shock, town, step-down, diuresis, cardiac stimulant.
14, dandelion: contain taraxasterol, taraxacin, taraxacin, synanthrin, choline, pectin etc.; Antibacterial, detoxifcation, anti-inflammatory, antiviral; Can significantly improve conversion ratio, the excitating organism immunocompetence of human peripheral blood lymphocytes mother cell, cholagogic, diuresis promote mammary gland secretion.
15, flea stops: contain steroid saponin (title pariphylin) flea and stop the peaceful glucoside of soil, (latter is hydrolyzed rear generation diosgenin), alkaloid, amino acid; Antibacterial, anti-inflammatory, detoxifcation, calmness, pain relieving have haemocylolysis.
16, field pennycress: contain volatile oil, patrinene, isovaleric acid (complex acid after the hydrolysis is oleanolic acid); Suppress germ, virus, prevent liver cell lesion, promote liver cell regeneration, the effects such as calmness, analgesia are arranged.
17, Phytolacca acinosa processed: contain triterpenoid saponin, sterols joint compound, alkaloid, jaligonic acid, starch etc.; The multiple pharmacological effect such as antibacterial, anti-inflammatory, diuresis.
Claims (1)
1, a kind of medicine for the treatment of lupus erythematosus, it is characterized in that it is to be made by the raw material of following weight proportioning: Radix Astragali 5g, Radix Angelicae Sinensis 5g, fruit of Chinese wolfberry 5g, barrenwort 5g, Fructus Corni 4g, bark of eucommia 4g, Psoralea corylifolia 3g, radix achyranthis bidentatae 4g, betel nut 4g, safflower 3g, seed of cowherb 4g, Sargent gloryvine 4g, capsule of weeping forsythia 3g, dandelion 4g, flea stop 2.5g, field pennycress 4g, Phytolacca acinosa 2.5g processed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021245827A CN1176699C (en) | 2002-06-21 | 2002-06-21 | Lupus treating medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021245827A CN1176699C (en) | 2002-06-21 | 2002-06-21 | Lupus treating medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1398614A CN1398614A (en) | 2003-02-26 |
CN1176699C true CN1176699C (en) | 2004-11-24 |
Family
ID=4745417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021245827A Expired - Fee Related CN1176699C (en) | 2002-06-21 | 2002-06-21 | Lupus treating medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1176699C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101095716B (en) * | 2007-07-05 | 2011-08-31 | 复旦大学 | Use of cortex eucommiae total polyoses in the preparing of the medicine for preventing and treating systematic lupus erythematosus |
-
2002
- 2002-06-21 CN CNB021245827A patent/CN1176699C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1398614A (en) | 2003-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103272169B (en) | Application of rhodiola rosea compound composite in treating erosive gastritis | |
CN1895557A (en) | Chinese-medicinal herb for treating hypertension, high-blood-fat and hyperglycosemia | |
CN101041046A (en) | Chinese traditional medicine compound took orally for treating morning diarrhea | |
CN101032593A (en) | Acne-treating Chinese medicine preparation | |
CN1857458A (en) | Health product and medicine and their preparing method | |
CN103877247A (en) | Medicine for treating bedsore and preparation method thereof | |
CN101041006A (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
CN1176699C (en) | Lupus treating medicine | |
CN106692909A (en) | Pyrus pyrifolia tree viscum coloratum grease with lung-clearing and phlegm-eliminating effects | |
CN102626477B (en) | Externally used traditional Chinese medicine combination for treating long-time traumatic injury | |
CN102038761A (en) | Medicament for treating rheumatoid diseases | |
CN101850044A (en) | Medicament for treating peptic ulcer and reflux esophagitis and preparation method thereof | |
CN1328847A (en) | Chinese medicine preparation for curing pneumoconiosis | |
CN103169863B (en) | Medicament for treating constipation and preparation method thereof | |
CN1259065C (en) | Chinese medicinal preparation for quick bone fracture setting | |
CN101073653A (en) | Chinese-medicinal powder for treating acne | |
CN1631388A (en) | Chinese traditional medicine for treating chronic prostatitis | |
CN1286101A (en) | Medicine for treating atrophic gastritis and its preparing process | |
CN113577137B (en) | Traditional Chinese medicine composition for treating acne and preparation method and application thereof | |
CN1533795A (en) | Chinese medicine for treating digestive ulcerating sore and its preparation method | |
CN1196953A (en) | Chinese patent drug for treating chronic bronchitis and asthma | |
CN1242772C (en) | Chinese medicine for hemorrhoid | |
CN1343517A (en) | Medicine for treating dermatopathy and its preparing process | |
CN1063061C (en) | Foot-bathing ointment of Chinese medicine | |
CN1095379C (en) | Chinese medicine for detoxicating wound and its preparing process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |